OhMD, founded in 2016, is positioned at the forefront of conversational patient engagement software. The company offers a solution that enables text-based communication and HIPAA-compliant texting for a multitude of medical practices and hospitals across the United States. By leveraging digital health technologies, OhMD effectively enhances patient engagement and satisfaction, while contributing positively to the overall health of patient populations.
Specializing in AI, Digital Health, Health Care, Messaging, and Telecommunications, OhMD has seen substantial growth in its niche. The company secured a $4.50M Seed Round investment on February 22, 2022, supported by notable investors such as FCA Venture Partners, GE Healthcare, Dudley Fund, Marathon Health, and OpenTempo. These partnerships highlight confidence in OhMD's potential to innovate in the healthcare communication space.